Le Lézard
Classified in: Health, Science and technology, Business
Subject: CXP

Koneksa Health Announces New U.S. Office


NEW YORK, Nov. 6, 2019 /PRNewswire/ -- Koneksa Health announced today the opening of its new corporate headquarters in New York. The company, which enables the biopharmaceutical industry to develop new medicines using digital biomarkers and novel clinical endpoints, also has an office in London as well as U.S.-based teams in Boston, Philadelphia and San Francisco. The new Koneksa headquarters are in New York's Financial District at 199 Water Street.

Koneksa Health logo (PRNewsfoto/Koneksa Health)

"Our rapid growth has driven us to expand our engineering team, so that we can continue to stay ahead of the industry's rapidly expanding demand for digital endpoints," said Chris Benko, Koneksa CEO.

The new headquarters includes a dedicated hardware testing lab.

"Koneksa's SaaS Solution is designed from the ground up to integrate and analyze data from a wide variety of wearables and mobile devices from manufacturers across the globe," said Rob Ellis, Head of Tech R&D at Koneksa. The critical requirement is data quality and patient usability as we continue to add new devices to our portfolio.  New devices are announced almost daily.  With our hardware lab and our industry-leading testing practices, we can quickly determine which devices are fit for purpose for our clients' studies."

The 199 Water offices embody many of the latest design features and best practices.

"We are excited to relocate to our new and larger office," said Vik Shah, Koneksa COO.  This move represents another significant milestone for our fast growth at Koneksa Health.  Our goal for the new office space is to accommodate our growing team and provide an environment that drives creativity, innovation and collaboration to achieve our mission. It also enables us to hire additional talent and host our customers in a beautiful and historical part of Manhattan."

About Koneksa Health

Koneksa Health is a private company that enables the biopharmaceutical industry to develop new medicines with fewer patients. By unlocking the potential of real-world data from remote, wearable, and other digital technologies, Koneksa speeds up the time required to understand how a drug is working and helps to develop real-world evidence for how medicines can impact the daily lives of patients.

For more information, please visit www.koneksahealth.com

SOURCE Koneksa Health Inc.


These press releases may also interest you

at 06:22
Sapiens International Corporation , a leading global provider of software solutions for the insurance industry, announced today that it will report its financial results for the first quarter of 2024 on Tuesday, May 8, 2024. Management will host a...

at 06:15
United Microelectronics Corporation ("UMC" or "The Company"), a leading global semiconductor foundry, today announced its consolidated operating results for the first quarter of 2024. First quarter consolidated revenue was NT$54.63 billion,...

at 06:13
Synchrony Financial today announced its first quarter 2024 results for the period ending March 31, 2024. The earnings news release, financial tables and related materials can be found on the company's investor relations website...

at 06:05
Hilton Worldwide Holdings Inc. ("Hilton," "the Company," "we," "us" or "our") today reported its first quarter 2024 results. Highlights include: Diluted EPS was $1.04 for the first quarter, and diluted EPS, adjusted for special items, was $1.53...

at 06:05
Summit Bank Group Q1 2024 Net Income - $2.4 million or $0.31 per fully diluted share. Q1 2024 Net Income increased from $0.30 per share for Q1 2023 and $0.22 per share for Q4 2023. Cash and Securities totaled $149.9 million ? 13.0 percent...

at 06:05
Thermo Fisher Scientific Inc. , the world leader in serving science, today reported its financial results for the first quarter ended March 30, 2024. First Quarter 2024 Highlights First quarter revenue was $10.34 billion. First quarter GAAP...



News published on and distributed by: